FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer

James L. Chen*, Daniel E. Appelbaum, Masha Kocherginsky, Charles L. Cowey, Wendy Kimryn Rathmell, David F. Mcdermott, Walter M. Stadler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences